Markus Haeberlein
Chief Tech/Sci/R&D Officer at ALKERMES PLC
Profile
Markus Haeberlein is currently working as a Senior Vice President-Research at Alkermes Plc.
Previously, he worked as a Director & Head-Medicinal Chemistry at AstraZeneca LP and as a Senior Vice President & Head-Research at Proteostasis Therapeutics, Inc. He holds graduate and doctorate degrees from the Royal Institute of Technology.
Markus Haeberlein active positions
Companies | Position | Start |
---|---|---|
ALKERMES PLC | Chief Tech/Sci/R&D Officer | - |
Former positions of Markus Haeberlein
Companies | Position | End |
---|---|---|
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Director/Board Member | - |
PROTEOSTASIS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Markus Haeberlein
Royal Institute of Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ALKERMES PLC | Health Technology |
Private companies | 2 |
---|---|
Proteostasis Therapeutics, Inc.
Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA. | Health Technology |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
- Stock Market
- Insiders
- Markus Haeberlein